Eye contact: Rinse immediately with plenty of water, also under the eyelids, for at least 15 minutes. Remove contact lenses, if present, after 5 minutes, then continue rinsing eye. Call a POISON CENTRE or doctor/physician.
Revlimid is a medicine used for the treatment of multiple myeloma, myelodysplastic syndromes and mantle cell lymphoma, which are conditions affecting blood cells and bone marrow. In multiple myeloma, a cancer of a type of white blood cells called plasma cells, Revlimid is used:
The other breakthrough in MDS, which Dr. List was involved with, was the development of lenalidomide (Revlimid, Celgene) as the first targeted agent for the disease. Lenalidomide, which is an immunomodulator used in the treatment of multiple myeloma, was approved by the FDA in 2005 for use in a subset of patients with MDS. The specific indication was patients with low-risk or intermediate-1 risk MDS with a deletion 5q cytogenetic abnormality.